Quantifying leukemia

被引：28

作者：

Morley, A ^{[1
]}

机构：

[1] Flinders Univ & Med Ctr, Adelaide, SA 5042, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 339卷 / 09期

关键词：

D O I：

10.1056/NEJM199808273390911

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：627 / 629

页数：3

共 10 条

[1] Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia [J].

Brisco, MJ ;

Sykes, PJ ;

Hughes, E ;

Dolman, G ;

Neoh, SH ;

Peng, LM ;

Toogood, I ;

Morley, AA .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :314-319

[2] OUTCOME PREDICTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA BY MOLECULAR QUANTIFICATION OF RESIDUAL DISEASE AT THE END OF INDUCTION [J].

BRISCO, MJ ;

CONDON, J ;

HUGHES, E ;

NEOH, SH ;

SYKES, PJ ;

SESHADRI, R ;

TOOGOOD, I ;

WATERS, K ;

TAURO, G ;

EKERT, H ;

MORLEY, AA .

LANCET, 1994, 343 (8891) :196-200

[3] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia [J].

Cavé, H ;

ten Bosch, JV ;

Suciu, S ;

Guidal, C ;

Waterkeyn, C ;

Otten, J ;

Bakkus, M ;

Thielemans, K ;

Grandchamp, B ;

Vilmer, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :591-598

[4] Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia [J].

Coustan-Smith, E ;

Behm, FG ;

Sanchez, J ;

Boyett, JM ;

Hancock, ML ;

Raimondi, SC ;

Rubnitz, JE ;

Rivera, GK ;

Sandlund, JT ;

Pui, CH ;

Campana, D .

LANCET, 1998, 351 (9102) :550-554

[5] Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia [J].

Dibenedetto, SP ;

LoNigro, L ;

Mayer, SP ;

Rovera, G ;

Schiliro, G .

BLOOD, 1997, 90 (03) :1226-1232

[6] Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response [J].

Foroni, L ;

Coyle, LA ;

Papaioannou, M ;

Yaxley, JC ;

Sinclair, MFC ;

Chim, JS ;

Cannell, P ;

SeckerWalker, LM ;

Mehta, AB ;

Prentice, HG ;

Hoffbrand, AV .

LEUKEMIA, 1997, 11 (10) :1732-1741

[7] Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia [J].

Goulden, NJ ;

Knechtli, CJC ;

Garland, RJ ;

Langlands, K ;

Hancock, JP ;

Potter, MN ;

Steward, CG ;

Oakhill, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (01) :235-244

[8] A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse [J].

Jacquy, C ;

Delepaut, B ;

VanDaele, S ;

Vaerman, JL ;

Zenenbergh, A ;

Brichard, B ;

Vermylen, C ;

Cornu, G ;

Martiat, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) :140-146

[9]

SYKES PJ, 1992, BIOTECHNIQUES, V13, P444

[10] RESIDUAL DISEASE AT THE END OF INDUCTION THERAPY AS A PREDICTOR OF RELAPSE DURING THERAPY IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

WASSERMAN, R ;

GALILI, N ;

ITO, Y ;

SILBER, JH ;

REICHARD, BA ;

SHANE, S ;

WOMER, RB ;

LANGE, B ;

ROVERA, G .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1879-1888

← 1 →